Efficacy of clindamycin in the treatment of Staphylococcus aureus osteomyelitis in dogs.
The efficacy of clindamycin in the treatment of experimentally induced, posttraumatic Staphylococcus aureus osteomyelitis was studied in dogs. At the end of the experiment, bacteria could not be isolated from bone marrow of 15 of 16 (93.7%) dogs treated with clindamycin, whereas bacteria could not be isolated from similar specimens obtained from 6 of 13 (46.1%) untreated dogs. None of the 16 dogs treated with clindamycin had histopathologic evidence of osteomyelitis at the end of the experiment. Five of the 13 untreated control dogs had histopathologic evidence of osteomyelitis. The recovery rate was 31% in untreated dogs, whereas 94% of dogs treated with clindamycin recovered from osteomyelitis. Clindamycin, 11 mg/kg of body weight, given orally, q 12 h, for 28 days, was efficacious in the treatment of experimentally induced, posttraumatic S aureus osteomyelitis in dogs.
Braden
T D
TD
Department of Small Animal Clinical Sciences, Michigan State University, East Lansing 48824-1316.
Johnson
C A
CA
Wakenell
P
P
Tvedten
H W
HW
Mostosky
U V
UV
D000818:Animals; D001842:Bone and Bones / Q000293:injuries; D002981:Clindamycin / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D010019:Osteomyelitis / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D013211:Staphylococcus aureus / Q000302:isolation & purification
D002981:Clindamycin